JP Morgan Maintains Neutral on ArcBest, Raises Price Target to $117

Benzinga Newsdesk www.benzinga.com Positive 49.5%

Neg 0% Neu 0% Pos 49.5%

JP Morgan analyst Brian Ossenbeck maintains ArcBest (NASDAQ:ARCB) with a Neutral and raises the price target from $85 to $117.